Skip to main content

Together we are beating cancer

Donate now

Cancer type

Showing 12 out of 2914 results

Cancer Research UK scientists have uncovered new insights into how a key pancreatic cancer drug – gemcitabine – is broken down in tumour cells Cancer Research UK scientists have uncovered new insights into how a key pancreatic cancer drug – gemcitabine – is broken down in tumour cells

by Cancer Research UK | News | 30 May 2014

30 May 2014

A team of our scientists have discovered how a key protein called fascin could help pancreatic cancer spread - we explore their findings A team of our scientists have discovered how a key protein called fascin could help pancreatic cancer spread - we explore their findings

by Nick Peel | Analysis | 20 May 2014

20 May 2014

Cancer Research UK logo

Cancer Research UK scientists have shown how switching off a key protein in pancreatic cells slows the spread of the disease to other tissues. Cancer Research UK scientists have shown how switching off a key protein in pancreatic cells slows the spread of the disease to other tissues.

by Cancer Research UK | News | 20 May 2014

20 May 2014

Multiple myeloma cells

Media outlets are awash with the news that researchers in the US have apparently cured cancer with the measles virus. What are the facts behind the headlines? Media outlets are awash with the news that researchers in the US have apparently cured cancer with the measles virus. What are the facts behind the headlines?

by Kat Arney | Analysis | 16 May 2014

16 May 2014

Mobile Phones

In the light of new research, we look again at the evidence on mobile phone use and brain tumours. In the light of new research, we look again at the evidence on mobile phone use and brain tumours.

by Sarah Williams | Analysis | 14 May 2014

14 May 2014

Cancer Research UK has launched a new trial to see if high doses of aspirin might help avoid hearing loss in patients given the drug cisplatin. Cancer Research UK has launched a new trial to see if high doses of aspirin might help avoid hearing loss in patients given the drug cisplatin.

by Cancer Research UK | News | 8 May 2014

8 May 2014

What happens when the development of a potential new drug stalls? Read how our Clinical Development Partnership scheme is giving some drugs a second chance. What happens when the development of a potential new drug stalls? Read how our Clinical Development Partnership scheme is giving some drugs a second chance.

by Alan Worsley | Analysis | 30 April 2014

30 April 2014